Nuance hands off 2 business units, leans hard into conversational AI

A new company called DeliverHealth Solutions is forming to service clients of Nuance’s HIM transcription and EHR go-live businesses.

Nuance is selling the units primarily to concentrate on attaining and sustaining market leadership in the booming conversational AI space, according to an announcement.

Nuance will remain close to existing customers of these product lines, however, since it will be a minority shareholder and technology partner of DeliverHealth.

The new independent entity is formed by the joining of two companies—the private equity firm Assured Healthcare Partners and the outsourcing outfit Aeries Technology Group.  

In the announcement, Nuance says the development signals its continuing interest in healthcare and enterprise markets.

Nuance CEO Mark Benjamin adds that the three-company transaction reflects the ongoing “dramatic acceleration in the digital transformation of healthcare.”

Watch for the trend to continue, Benjamin suggests, “as organizations deploy the power of conversational AI and deeply integrated cloud-based solutions at scale to address physician burnout, expand patient access, and improve system efficiencies and the revenue cycle.”

Conversational AI is the branch focused on getting chatbots and other digital interfaces to talk to humans in natural speech patterns. The market for the technology has been forecast to top $18 billion by 2027, up from less than $5 billion in 2020.

At the sale’s closing, Michael Clark, currently a senior VP and GM with Nuance, will become DeliverHealth’s CEO.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”